MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 5, 2012, Pages 424-430

  Hu, Huajun ^a,b   Li, Shangao ^c   Liu, Jun ^a,b   Ni, Bin ^a,b  

^a CHINA JILIANG UNIVERSITY   (China)

^b Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; MicroRNA 193b; Migration; NSCLC; Proliferation

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; MICRORNA; MIRN193 MICRORNA, HUMAN; UROKINASE;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84860445099     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms018     Document Type: Article

References (18)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61: 69-90.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ. Cancer statistics. CA Cancer J Clin 2009, 59: 225-249.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
4. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6: 259-269.
5. Lin PY, Yu SL and Yang PC. MicroRNA in lung cancer. Br J Cancer 2010, 103: 1144-1148.
6. Wu W, Lin Z, Zhuang Z and Liang X. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev 2009, 18: 50-55.
7. Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL and Oja H, et al. miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 2010, 127: 1363-1372.
8. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K and Enerly E, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009, 28: 3926-3936.
9. Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J and Xing R, et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 2010, 46: 2828-2836.
10. Chen J, Feilotter HE, Pare GC, Zhang X, Pemberton JG, Garady C and Lai D, et al. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010, 176: 2520-2529.
11. Li XF, Yan PJ and Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 2009, 28: 3937-3948.
12. Nigg EA. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 1995, 17: 471-480.
13. Knudsen KE, Diehl JA, Haiman CA and Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006, 25: 1620-1628.
14. Klein EA and Assoian RK. Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 2008, 121: 3853-3857.
15. Chapman HA. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 1997, 9: 714-724. (Pubitemid 27424929)
16. Sidenius N and Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 2003, 22: 205-222. (Pubitemid 36561058)
17. Pulukuri SM and Rao JS. Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis. Cancer Res 2007, 67: 6637-6646. (Pubitemid 47105509)
18. Dass K, Ahmad A, Azmi AS, Sarkar SH and Sarkar FH. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 2008, 34: 122-136.